If you are thinking about selling your dental practice, the first question most principals ask is straightforward: how much is it actually going to sell for?
The honest answer is that dental practice sale prices vary considerably — from under £500,000 for a small NHS practice in a challenging area to over £3 million for a large, well-established private practice. But within those extremes, there are clear patterns. This article sets out realistic sale price benchmarks by practice type, explains the factors that drive price within each band, and gives you a practical way to estimate where your practice is likely to land.
How Dental Practices Are Priced
Dental practices are valued on a normalised EBITDA multiple basis. That means:
- The buyer calculates the sustainable annual profit the practice generates after removing owner-specific costs (personal vehicle, pension above market rate, family salary above market rate, etc.)
- They apply a multiple to that figure, based on the practice’s risk profile, revenue mix, and the competitive tension in the buyer process
The multiple typically ranges from 4× to 10× EBITDA depending on practice type. Revenue mix is the dominant driver: private and mixed practices command higher multiples than NHS-only practices.
Sale Price Benchmarks by Practice Type
NHS-Only Practices
Typical EBITDA multiple: 4–6× normalised EBITDA
What drives price within this range:
- UDA value (£28–£38/UDA depending on ICB area; higher value = higher price)
- NHS delivery track record (under-delivery discounts the multiple)
- ICB relationship (any outstanding clawback or renewal uncertainty?)
- Number of surgeries and patient list size
Example sale price scenarios:
| Normalised EBITDA | Multiple | Indicative Sale Price |
|---|---|---|
| £100,000 | 4.5× | £450,000 |
| £150,000 | 5× | £750,000 |
| £200,000 | 5.5× | £1,100,000 |
| £250,000 | 5× | £1,250,000 |
A mid-sized NHS practice generating £150k–£200k normalised EBITDA would typically achieve £750k–£1.1m in the current market, assuming a clean CQC record and consistent NHS delivery.
Mixed NHS/Private Practices
Typical EBITDA multiple: 5–8× normalised EBITDA
Mixed practices attract a wider buyer pool than NHS-only practices, including:
- Independent buyers who want a stable NHS income foundation with private growth potential
- DSOs that are scaling NHS capacity in a specific geography
- PE-backed groups targeting mixed practices as a platform
What drives price within this range:
- Private income as a percentage of total revenue (higher = higher multiple)
- Quality of the NHS contract (UDA value, delivery record)
- Whether the private income is associate-generated or principal-dependent
- CQC rating
Example sale price scenarios:
| Normalised EBITDA | Mix (NHS:Private) | Indicative Multiple | Indicative Sale Price |
|---|---|---|---|
| £150,000 | 70:30 | 5.5× | £825,000 |
| £200,000 | 60:40 | 6× | £1,200,000 |
| £250,000 | 50:50 | 7× | £1,750,000 |
| £300,000 | 40:60 | 7.5× | £2,250,000 |
A practice with a genuinely balanced NHS/private revenue split and a strong clinical team — particularly one where private income is not concentrated in the selling principal — is one of the most attractive acquisition targets in the current dental M&A market.
Private-Only Practices
Typical EBITDA multiple: 6–10× normalised EBITDA
Private practices command the highest multiples and attract the broadest buyer pool including:
- Individual dentists seeking a prestigious private principal position
- High-end DSOs and private equity buyers
- International dental groups expanding into the UK market
The caveat: the EBITDA must be genuine. A private practice where the principal’s personal clinical income accounts for the majority of revenue will see a significant earn-out requirement built into any DSO offer, reflecting the key-person risk.
What drives price within this range:
- Whether revenue is principal-dependent or associate-built
- Specialty services (implants, orthodontics, cosmetic dentistry — all add value)
- Location and patient demographic
- Practice reputation and online reviews
- Whether there is a stable, contracted associate team
Example sale price scenarios:
| Normalised EBITDA | Notes | Indicative Multiple | Indicative Sale Price |
|---|---|---|---|
| £150,000 | Small, principal-heavy | 6× | £900,000 |
| £200,000 | Mixed associate/principal | 7× | £1,400,000 |
| £300,000 | Strong associate team, specialty services | 8× | £2,400,000 |
| £500,000 | Multiple surgeries, premium location | 9–10× | £4,500,000–£5,000,000 |
The Normalisation Question: What Counts as EBITDA?
The most common mistake practices make when estimating their own value is using the raw profit figure from the accounts without normalisation.
Costs typically removed in normalisation:
- Principal’s drawings or salary above a market-rate associate replacement (typically £80,000–£110,000 for a full-time clinical replacement)
- Personal vehicle costs charged through the practice
- Life assurance and income protection above employer norms
- Pension contributions above a standard employer contribution level
- Family members’ salaries where their role would not exist under new ownership
- One-off legal or accountancy costs that won’t recur
A practice showing £120,000 net profit in its accounts may have a normalised EBITDA of £180,000–£220,000 after these adjustments. That difference can change the exit value by £200,000–£400,000.
Your accountant is the best person to work through this normalisation before you engage a broker. Getting this number right is the most valuable preparation step you can take.
How NHS Contract Novation Affects the Sale Price
For NHS and mixed practices, the NHS contract does not transfer automatically — it must be approved by NHS England or the Integrated Care Board through a formal novation process. This takes 3–6 months and is typically the primary driver of the overall transaction timeline.
Novation does not directly affect the headline sale price, but it does affect:
- The profile of buyers who can complete (smaller buyers without NHS experience may struggle)
- The certainty of the transaction (both parties are exposed to novation risk)
- The use of deferred consideration (some buyers include a novation contingency in the heads of terms)
For a full explanation of the novation process, see our guide on NHS contract novation when selling a dental practice.
DSO vs Independent Buyer: Does It Affect Sale Price?
The short answer: it depends on how you measure it.
DSOs (corporate groups and PE-backed buyers) may offer a higher headline price, but often with earn-out conditions — typically 12–24 months of deferred consideration contingent on the practice meeting post-acquisition performance targets. The “real” price is the upfront payment plus whatever earn-out is achieved.
Independent buyers typically offer a lower headline price but with a cleaner deal structure — a single payment at completion with no deferred risk.
On a risk-adjusted basis, the difference is often smaller than it appears. A well-run competitive process with both buyer types is the most reliable way to achieve the best outcome across both price and terms. For more on this, see our guide on selling to a DSO or independent buyer.
What Reduces the Sale Price
The following factors consistently lead to discount offers or a narrower buyer pool:
- CQC “Requires Improvement” rating — most buyers will not complete with an outstanding CQC improvement notice
- NHS under-delivery — buyers model the income at delivered levels, not contracted allocation
- High principal dependency — revenue that will leave with the selling dentist is discounted or deferred
- Unsigned or verbal associate agreements — creates legal and operational uncertainty
- Short lease term remaining — particularly problematic for leaseholders with fewer than 10 years remaining
- Outstanding HMRC correspondence — any unresolved tax position creates acquirer risk
Addressing these before going to market does not just improve the price — it determines whether a transaction can complete at all.
Getting Your Number
The practical starting point is a confidential valuation from a specialist dental practice broker. This is not the same as asking your accountant to run a quick multiple on last year’s accounts — a proper valuation takes into account the specific buyer market for your practice type, your NHS contract position, your clinical team, your location, and the current market dynamics.
The Business Acquisitions Group provides free confidential valuations for dental practice owners who are considering a sale in the next 1–5 years. There is no obligation attached — a valuation is just information.
Get a free confidential dental practice valuation →
For more context on how valuations are calculated, read our detailed guide on how UK dental practices are valued.
Frequently Asked Questions
How much is the average dental practice worth in the UK?
There is no single “average” — sale prices range from under £500,000 for small NHS-only practices to over £3 million for large established private practices. The most important variables are EBITDA (after normalisation), revenue mix (NHS vs private), and the CQC rating and NHS delivery track record.
Do private dental practices sell for more than NHS practices?
Private practices command higher EBITDA multiples (6–10× vs 4–6× for NHS-only practices). But the absolute sale price depends on the underlying EBITDA — a large, well-run NHS practice with high UDA values can achieve a higher total price than a small private practice on a lower absolute EBITDA.
How is a dental practice EBITDA calculated for sale purposes?
Normalised EBITDA is calculated by taking the net profit, adding back depreciation and amortisation, and then removing owner-specific costs that won’t recur post-sale (personal vehicle costs, above-market pension contributions, family salary costs above market rate, etc.). The result is the sustainable maintainable earnings that a buyer will use to apply their multiple. See our full guide on dental practice EBITDA.
What is a typical EBITDA multiple for a dental practice?
NHS-only practices: 4–6×. Mixed NHS/private: 5–8×. Private-only: 6–10×. These ranges reflect the buyer demand and risk profile for each practice type. The specific multiple within the range is determined by the competitive tension in the sale process, the quality of the clinical team, the NHS contract position, and the practice’s CQC rating.
How long does it take to sell a dental practice?
For a well-prepared practice: 12–18 months from instruction to completion for NHS and mixed practices (the additional time reflects the NHS contract novation process); 6–12 months for private-only practices. See our full guide on how long it takes to sell a dental practice.